Skip to content

Drug interactions

Fluticasone-salmeterol + Larotrectinib

Severity: Minor

Fluticasone-salmeterol and Larotrectinib: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Larotrectinib is a CYP3A4 substrate and a weak CYP3A4 inhibitor in vitro, so it may slightly raise fluticasone exposure. The effect with inhaled doses is probably negligible in practice.

What this interaction means in plain words

Fluticasone-salmeterol and Larotrectinib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Fluticasone-salmeterol belongs to Respiratory; Larotrectinib belongs to Oncology.

Evidence level: Low

Why it happens

Possible weak CYP3A4 inhibition by larotrectinib reduces fluticasone metabolism; the mechanism is not firmly established.

What to do

No specific action is needed beyond awareness. Monitor for signs of corticosteroid excess in long-term concurrent use.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Fluticasone-salmeterol and Larotrectinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Fluticasone-salmeterol with Larotrectinib?

MediHelp rates the interaction as minor. Fluticasone-salmeterol and Larotrectinib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Larotrectinib is a CYP3A4 substrate and a weak CYP3A4 inhibitor in vitro, so it may slightly raise fluticasone exposure. The effect with inhaled doses is probably negligible in practice.

How serious is the interaction between Fluticasone-salmeterol and Larotrectinib?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No specific action is needed beyond awareness. Monitor for signs of corticosteroid excess in long-term concurrent use.

What other medicines interact with Fluticasone-salmeterol?

MediHelp also lists interactions of Fluticasone-salmeterol with, for example, Darunavir, Elvitegravir / cobicistat / emtricitabine / tenofovir df, Fosamprenavir. The full list is on the Fluticasone-salmeterol page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in